nRichDX launches high-yield sample prep platform for liquid biopsies

2019 07 25 22 25 7960 Lab Blood Plasma 400

nRichDX has launched its Revolution system, a high-yield sample prep IVD platform that delivers exponentially more target input for molecular assays, increasing the sensitivity of liquid biopsy-based tests.

Revolution's increase in target yield is accomplished by combining the ability to process a wide range of sample volumes, from 3 mL to 50 mL, with high recovery rates of 70% to 90%.

The system's initial use involves the extraction of cell-free DNA (cfDNA) from plasma and urine with applications for circulating tumor cells (CTCs), exosomes, and total cell-free nucleic acid in the development pipeline.

nRichDX will showcase Revolution at the Association for Molecular Pathology (AMP) meeting taking place November 7-9 at the Baltimore Convention Center.

Page 1 of 164
Next Page